SCHEMBL4629064

SCHEMBL4629064

CCc1cc(OC)cc(CC)c1Cc1c[nH]c(-c2nc(Cc3c(CC)ccc(OC)c3CC)c[nH]2)n1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE10A Q9Y233 5/20 0.32
ALDH1A1 P00352 1/20 0.31
DHFR P00374 2/20 0.31
IDO1 P14902 2/20 0.31
ADRA1A P35348 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
PDE4B Q07343 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31
KCNH2 Q12809 1/20 0.31
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
MTNR1A P48039 1/20 0.30
MTNR1B P49286 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2103689 0.72 KDM4E (0.30) KDM4ETAAR1
SCHEMBL14999441 0.69 TAAR1 (0.39) HSD17B10KDM4ETAAR1HSP90AA1
SCHEMBL2626856 0.68 ADRA1D (0.42) SMN1; SMN2TAAR1
SCHEMBL2103293 0.67 PDE10A (0.31) PDE10ADHFRKCNH2
SCHEMBL953878 0.67 TAAR1 (0.62) KDM4ESMN1; SMN2ALDH1A1ADRA1ATAAR1
SCHEMBL10044604 0.66 CYP1A2 (0.46) HSD17B10SMN1; SMN2ALDH1A1ADRA1ATAAR1
SCHEMBL2626855 0.65 CYP19A1 (0.48) TAAR1
SCHEMBL31429728 0.64 CYP3A4 (0.38) SMN1; SMN2ALDH1A1MTNR1AMTNR1B
SCHEMBL2952706 0.64 CA2 (0.43) KDM4ESMN1; SMN2ADRA1ATAAR1HSP90AA1
SCHEMBL4630237 0.64 TAAR1 (0.56) TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981880-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-22 EP claimed
WO-2007085556-A2 USE OF 4-IMIDAZOLE DERIVATIVES FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-02 WO claimed